Rhythm Pharmaceuticals Inc (RYTM)
49.63
+1.05
(+2.16%)
USD |
NASDAQ |
Oct 04, 16:00
49.70
+0.08
(+0.15%)
After-Hours: 20:00
Rhythm Pharmaceuticals Shareholders Equity (Annual): 169.76M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 169.76M |
| December 31, 2022 | 264.26M |
| December 31, 2021 | 284.15M |
| December 31, 2020 | 166.53M |
| December 31, 2019 | 281.02M |
| Date | Value |
|---|---|
| December 31, 2018 | 246.26M |
| December 31, 2017 | 144.79M |
| December 31, 2016 | 7.297M |
| December 31, 2015 | 32.00M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
166.53M
Minimum
2020
284.15M
Maximum
2021
233.14M
Average
264.26M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Eli Lilly and Co | 10.77B |
| Regeneron Pharmaceuticals Inc | 25.97B |
| TG Therapeutics Inc | 160.50M |
| Mirum Pharmaceuticals Inc | 248.67M |
| Moderna Inc | 13.85B |